Emami posts 11% core domestic growth in Q4, declares special dividend on 50th anniversary

Emami posts 11% core domestic growth in Q4, declares special dividend on 50th anniversary


Play all audios:


The company’s core domestic business delivered double-digit growth of 11%, with a healthy 7% volume growth, led by strong performance across key brands such as Navratna, Dermicool, BoroPlus,


and its healthcare portfolio. Emami also reported a 6% rise in international business, bolstered by momentum across SAARC, Southeast Asia, CIS, and African markets.


For the quarter, Emami posted a ten-basis point improvement in gross margins to 65.9%, while EBITDA rose 4% to ₹219 crore. Profit before tax grew 14% to ₹194 crore, and profit after tax


increased by 9% to ₹162 crore.


In FY25, the company’s consolidated revenue stood at ₹3,809 crore, a 6% increase over the previous fiscal. Gross margins expanded by 100 basis points to 68.6%, while EBITDA grew 8% to ₹1,025


crore. Profit before tax grew by 13% to ₹894 crore, and profit after tax rose 11% to ₹806 crore. EBITDA margins for the year improved to 26.9%.


Marking its 50th anniversary, the Board of Directors declared a special dividend of ₹2 per share, taking the total dividend payout for FY25 to ₹10 per share, equivalent to 54% of the


company’s net profit.


During the quarter, Emami undertook strategic brand portfolio transformations, including the rebranding of Fair and Handsome to Smart and Handsome, backed by a six-week national campaign


featuring actor Kartik Aaryan. The company also entered the brightening cream category with the launch of Emami Pure Glow, featuring actress Raashii Khanna as its brand ambassador. Over 25


new products were launched in the domestic market during the year.


Organised trade channels—comprising modern trade, e-commerce, and institutional sales—accounted for 27.6% of domestic revenue in FY25, with growth in these channels outpacing the overall


domestic business at 13% over the corresponding period last year.


Emami’s D2C and digital-first strategy continued to scale, with recent product launches contributing around 50% of total sales on its Zanducare platform. The company’s distribution


initiatives, including a sharper focus on GT-marts, also significantly expanded outlet-level purchase potential.